Revenue: The sum of all revenue fields included for a company's operating activities.
Tonix Pharmaceuticals Holding Corp. (TNXP) had Revenue of $10.09M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$10.09M |
$-130.04M |
|
$7.76M |
|
$2.33M |
|
$146.79M |
|
$-136.70M |
|
$6.67M |
|
$-130.04M |
|
$-130.04M |
|
$-130.04M |
|
$-130.04M |
|
$-130.04M |
|
$-130.04M |
|
$-136.70M |
|
$-132.44M |
|
0.74M |
|
0.74M |
|
$-176.60 |
|
$-176.60 |
|
| Balance Sheet Financials | |
$119.00M |
|
$42.25M |
|
$43.89M |
|
$162.89M |
|
$18.31M |
|
$4.67M |
|
$5.03M |
|
$23.33M |
|
$139.56M |
|
$139.44M |
|
$139.56M |
|
4.39M |
|
| Cash Flow Statement Financials | |
$-60.92M |
|
$-0.12M |
|
$134.87M |
|
$25.85M |
|
$99.68M |
|
$73.83M |
|
$4.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.50 |
|
-- |
|
-- |
|
0.03 |
|
0.05 |
|
23.07% |
|
-1354.28% |
|
-1354.28% |
|
-1312.07% |
|
-1288.25% |
|
-1288.25% |
|
$-61.05M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.92 |
|
2.74 |
|
133.18 |
|
-93.18% |
|
-93.26% |
|
-79.83% |
|
-90.16% |
|
$31.82 |
|
$-82.90 |
|
$-82.74 |
|